"Vaccines, Attenuated" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Live vaccines prepared from microorganisms which have undergone physical adaptation (e.g., by radiation or temperature conditioning) or serial passage in laboratory animal hosts or infected tissue/cell cultures, in order to produce avirulent mutant strains capable of inducing protective immunity.
Descriptor ID |
D014613
|
MeSH Number(s) |
D20.215.894.811
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Vaccines, Attenuated".
Below are MeSH descriptors whose meaning is more specific than "Vaccines, Attenuated".
This graph shows the total number of publications written about "Vaccines, Attenuated" by people in this website by year, and whether "Vaccines, Attenuated" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1998 | 1 | 0 | 1 |
2002 | 0 | 1 | 1 |
2005 | 0 | 1 | 1 |
2008 | 1 | 1 | 2 |
2011 | 0 | 1 | 1 |
2014 | 0 | 1 | 1 |
2015 | 0 | 1 | 1 |
2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Vaccines, Attenuated" by people in Profiles.
-
Engineering the common cold to be a live-attenuated SARS-CoV-2 vaccine. Front Immunol. 2022; 13:871463.
-
Effects of different vaccine combinations against Mycoplasma gallisepticum on the digestive and reproductive organ characteristics of commercial egg-laying hens. Poult Sci. 2015 Dec; 94(12):2898-904.
-
Effects of Mycoplasma gallisepticum vaccination on serum a1-acid glycoprotein concentrations in commercial layer chickens. Poult Sci. 2014 Jun; 93(6):1396-402.
-
Safety and immunogenicity of early measles vaccination in children born to HIV-infected mothers in the United States: results of Pediatric AIDS Clinical Trials Group (PACTG) protocol 225. J Infect Dis. 2011 Jul; 204 Suppl 1:S179-89.
-
Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007. Pediatrics. 2008 Jun; 121(6):1206-12.
-
Effects of time-specific F-strain Mycoplasma gallisepticum inoculation overlays on prelay ts11-strain Mycoplasma gallisepticum inoculation on performance characteristics of commercial laying hens. Poult Sci. 2008 Apr; 87(4):655-60.
-
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005 Jun 02; 352(22):2271-84.
-
Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J Infect Dis. 2002 Apr 15; 185(8):1155-64.
-
Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria. J Infect Dis. 1998 Jun; 177(6):1664-73.
-
Correlation between amount of virus with altered nucleotide sequence and the monkey test for acceptability of oral poliovirus vaccine. Proc Natl Acad Sci U S A. 1991 Jan 01; 88(1):199-203.